| Dr Uzma Farooq, MD | |
|
4665 Ponce De Leon Blvd, Coral Gables, FL 33146-2101 | |
| (305) 666-3471 | |
| Not Available |
| Full Name | Dr Uzma Farooq |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 21 Years |
| Location | 4665 Ponce De Leon Blvd, Coral Gables, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467617506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | ME97853 (Florida) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | ME97853 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Hospital Of Miami | Miami, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Group Of Florida, P.a. | 1153367107 | 42 |
| Marian Davis Dpm Pa | 1355415050 | 3 |
| Debra Price Md Pa | 3375572977 | 5 |
| Comprehensive Pathology Associates, P.a. | 7113825142 | 17 |
| Bay Dermatology And Cosmetic Surgery Pa | 7517851215 | 20 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Comprehensive Pathology Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871567289 PECOS PAC ID: 7113825142 Enrollment ID: O20031229000518 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Bay Dermatology And Cosmetic Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437148996 PECOS PAC ID: 7517851215 Enrollment ID: O20040212000454 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Vitalmd Group Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871572032 PECOS PAC ID: 8921091786 Enrollment ID: O20040406001878 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Mark And Kambour Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760456172 PECOS PAC ID: 0840258646 Enrollment ID: O20041227000613 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Dermatology Group Of Florida, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497806459 PECOS PAC ID: 1153367107 Enrollment ID: O20050630000181 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Debra Price Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477556801 PECOS PAC ID: 3375572977 Enrollment ID: O20050804000237 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Marian Davis Dpm Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962674903 PECOS PAC ID: 1355415050 Enrollment ID: O20080729000565 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Joseph C Gretzula Do Faad Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033102801 PECOS PAC ID: 7113064122 Enrollment ID: O20091023000479 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | Alejandro Pedrozo Iii, M.d. P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972925725 PECOS PAC ID: 8224092952 Enrollment ID: O20140218001571 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | The Derm Group Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801448519 PECOS PAC ID: 9335478908 Enrollment ID: O20190906001097 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Entity Name | One Path Diagnostics Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Clinical Laboratory |
| Entity Identifiers | NPI Number: 1679229942 PECOS PAC ID: 2567841778 Enrollment ID: O20220617002189 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Uzma Farooq, MD 4665 Ponce De Leon Blvd, Coral Gables, FL 33146-2101 Ph: (305) 666-3471 | Dr Uzma Farooq, MD 4665 Ponce De Leon Blvd, Coral Gables, FL 33146-2101 Ph: (305) 666-3471 |
News Archive
Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections.
New research published in the February issue of the Journal of the American College of Surgeons suggests that a traditional, "open" appendectomy may be preferable to a less-invasive laparoscopic appendectomy for the majority of patients with acute appendicitis, contrary to recent trends.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.
Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.
› Verified 5 days ago
Patricia I Delgado, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5000 University Dr, Coral Gables, FL 33146 Phone: 305-669-3471 | |
Silvio S Tanev, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5000 University Dr, Coral Gables, FL 33146 Phone: 305-669-3471 | |
Ana Viciana, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5000 University Dr, Coral Gables, FL 33146 Phone: 305-669-3471 | |
Dr. Sherry Marie Thompson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4665 Ponce De Leon Blvd, Coral Gables, FL 33146 Phone: 786-268-6050 | |
Dr. Janice Aportela, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4665 Ponce De Leon Blvd, Coral Gables, FL 33146 Phone: 786-464-0749 | |
Dr. Milantia Roy, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5000 University Dr, Pathology Department, Coral Gables, FL 33146 Phone: 305-669-3471 | |
Dr. Robert I Kendall, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2500 S Douglas Rd Ste A, Coral Gables, FL 33134 Phone: 305-442-0800 Fax: 305-442-0812 |